How CPHI South East Asia 2026 Is Driving the Next Wave of Pharma Growth

As Southeast Asia continues to emerge as one of the world's most promising pharmaceutical markets, CPHI South East Asia 2026 is set to return to the Queen Sirikit National Convention Center (QSNCC) in Bangkok, Thailand, bringing together pharmaceutical leaders, manufacturers, suppliers, innovators, and decision-makers from across the global healthcare value chain.

Taking place from 8–10 July 2026, the event is expected to welcome more than 10,000 attendees from over 70 countries, alongside 400+ exhibitors and 60+ industry seminars, reaffirming its position as the leading pharmaceutical trade exhibition and conference in the ASEAN region.

Unlocking Opportunities in ASEAN's Pharmaceutical Industry

Driven by growing healthcare demand, expanding manufacturing capabilities, and increasing investment in pharmaceutical innovation, ASEAN has become a strategic destination for pharmaceutical companies seeking new growth opportunities. Against this backdrop, CPHI South East Asia serves as a vital gateway for businesses looking to enter, expand, or strengthen their presence within the region.

The event provides a comprehensive platform where stakeholders across the pharmaceutical supply chain can connect, collaborate, and explore emerging market opportunities. From active pharmaceutical ingredients (APIs) and excipients to packaging, contract manufacturing, finished dosage formulations, and advanced pharmaceutical technologies, CPHI South East Asia covers the entire spectrum of the industry.

Connecting the Global Pharmaceutical Supply Chain

Organized annually by Informa Markets, CPHI South East Asia has established itself as a premier meeting place for pharmaceutical professionals seeking meaningful business connections and long-term partnerships.

The event brings together:

• API and raw material suppliers

• Pharmaceutical ingredient manufacturers

• Contract development and manufacturing organizations (CDMOs)

• Packaging and drug delivery solution providers

• Technology and equipment suppliers

• Finished product manufacturers

• Regulatory experts and industry consultants

By gathering these sectors under one roof, the exhibition creates valuable opportunities for networking, sourcing, knowledge sharing, and strategic collaboration.

A Platform for Innovation and Industry Advancement

Beyond the exhibition floor, CPHI South East Asia 2026 will feature an extensive conference program designed to address the latest trends, challenges, and innovations shaping the pharmaceutical landscape.

More than 60 expert-led seminars are expected to explore topics including: 

• Pharmaceutical manufacturing advancements

• API and ingredient innovation

• Regulatory developments

• Supply chain resilience

• Digital transformation in pharma

• Sustainability initiatives

• Emerging ASEAN market opportunities

Industry leaders, innovators, and thought leaders will share insights into the future of pharmaceutical development and commercialization, helping attendees stay ahead in an increasingly competitive global market.

Why Industry Professionals Attend

For pharmaceutical executives and procurement teams, the event offers a unique opportunity to connect with the global supply chain while discovering new products, technologies, and business partners.

Key benefits for attendees include:

• Access to a diverse international supplier network

• Direct engagement with industry experts and innovators

• Market intelligence and trend analysis

• Business matchmaking opportunities

• Year-round networking through digital and in-person platforms

As pharmaceutical companies continue to navigate evolving market dynamics, events such as CPHI South East Asia provide essential opportunities to build relationships, identify new suppliers, and secure future growth.

Driving Business Growth for Exhibitors

For exhibitors, CPHI South East Asia remains one of the most effective platforms for generating high-value leads and expanding market reach within Southeast Asia.

Companies exhibiting at the event benefit from:

• Valuable lead generation and customer acquisition

• Access to international buyers and decision-makers

• Enhanced brand visibility and industry recognition

• Opportunities to showcase innovations and new product launches

• Direct engagement with pharmaceutical manufacturers and distributors

With ASEAN's pharmaceutical sector projected to maintain strong growth momentum in the coming years, exhibitors can leverage the event to establish strategic partnerships and unlock new commercial opportunities.

Looking Ahead to CPHI South East Asia 2026

As the pharmaceutical industry continues to evolve through innovation, regional integration, and global collaboration, CPHI South East Asia 2026 stands as a key platform for shaping the future of healthcare manufacturing and supply chains across ASEAN.

By combining a world-class exhibition, industry-leading educational content, and unparalleled networking opportunities, the event is expected to once again serve as a catalyst for business growth, knowledge exchange, and pharmaceutical innovation throughout Southeast Asia and beyond.

For companies seeking to connect with the ASEAN pharmaceutical market, discover emerging trends, and build lasting industry partnerships, CPHI South East Asia 2026 offers an unparalleled opportunity to engage with the region's rapidly expanding pharmaceutical ecosystem.

Event Details:

Dates: July 8-10,2026

Location: QSNCC, Bangkok

Website: https://www.cphi.com/sea